Compound ID | 1052
Class: Aminoglycoside
| Spectrum of activity: | Gram-negative |
| Details of activity: | DNA Synthesis inhibitor |
| Institute where first reported: | The UpJohn Company |
| Year first mentioned: | 1976 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Reason Dropped: | "lack of clinical promise" |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/10409115 |
| Guide to Pharmacology: | feldamycin |
| Citations: |
|